^O’Donoghue, Michelle L.; Rosenson, Robert S.; Gencer, Baris; López, J. Antonio G.; Lepor, Norman E.; Baum, Seth J.; Stout, Elmer; Gaudet, Daniel; Knusel, Beat; Kuder, Julia F.; Ran, Xinhui; Murphy, Sabina A.; Wang, Huei; Wu, You; Kassahun, Helina; Sabatine, Marc S. (17 November 2022). "Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease". New England Journal of Medicine. 387 (20): 1855–1864. doi:10.1056/NEJMoa2211023.
^Koren, Michael J.; Moriarty, Patrick Maurice; Baum, Seth J.; Neutel, Joel; Hernandez-Illas, Martha; Weintraub, Howard S.; Florio, Monica; Kassahun, Helina; Melquist, Stacey; Varrieur, Tracy; Haldar, Saptarsi M.; Sohn, Winnie; Wang, Huei; Elliott-Davey, Mary; Rock, Brooke M.; Pei, Tao; Homann, Oliver; Hellawell, Jennifer; Watts, Gerald F. (January 2022). "Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)". Nature Medicine. 28 (1): 96–103. doi:10.1038/s41591-021-01634-w. ISSN 1546-170X.
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
olpasiran, amg890, experimental, antisense, therapy, designed, lower, level, lipoprotein, which, believed, causal, factor, development, cardiovascular, disease, drug, developed, amgen, references, edit, donoghue, michelle, rosenson, robert, gencer, baris, lópe. Olpasiran AMG890 is an experimental antisense therapy designed to lower the level of lipoprotein a which is believed to be a causal factor in the development of cardiovascular disease The drug is developed by Amgen 1 2 References edit O Donoghue Michelle L Rosenson Robert S Gencer Baris Lopez J Antonio G Lepor Norman E Baum Seth J Stout Elmer Gaudet Daniel Knusel Beat Kuder Julia F Ran Xinhui Murphy Sabina A Wang Huei Wu You Kassahun Helina Sabatine Marc S 17 November 2022 Small Interfering RNA to Reduce Lipoprotein a in Cardiovascular Disease New England Journal of Medicine 387 20 1855 1864 doi 10 1056 NEJMoa2211023 Koren Michael J Moriarty Patrick Maurice Baum Seth J Neutel Joel Hernandez Illas Martha Weintraub Howard S Florio Monica Kassahun Helina Melquist Stacey Varrieur Tracy Haldar Saptarsi M Sohn Winnie Wang Huei Elliott Davey Mary Rock Brooke M Pei Tao Homann Oliver Hellawell Jennifer Watts Gerald F January 2022 Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein a Nature Medicine 28 1 96 103 doi 10 1038 s41591 021 01634 w ISSN 1546 170X nbsp This pharmacology related article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title Olpasiran amp oldid 1196288668, wikipedia, wiki, book, books, library,